Status:
COMPLETED
Spermotrend in the Treatment of Male Infertility
Lead Sponsor:
Catalysis SL
Conditions:
Male Infertility
Eligibility:
MALE
19-60 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to determine whether the administration of the dietary supplement Spermotrend improves spermatogenesis parameters in subjects with male infertility unrelated to major test...
Eligibility Criteria
Inclusion
- Male infertility unrelated to major testicular conditions
- Must have at least one altered seminal parameter.
- Signed informed consent
Exclusion
- Hydrocele, varicocele, orchitis, epididymitis, irradiation or Chemotherapy.
- Previously treated and cured testicular condition.
- Non-transmissible chronic diseases
- Use of antioxidant agents within 6 months.
- Use of vitamins within 6 months.
- Use of anti-inflammatory drugs within 6 months.
- Use of hormones prescribed by an andrologist within 6 months
- Positive serology/HIV
- Leukocytospermia
Key Trial Info
Start Date :
September 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2011
Estimated Enrollment :
86 Patients enrolled
Trial Details
Trial ID
NCT00975117
Start Date
September 1 2009
End Date
March 1 2011
Last Update
March 8 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
"Ramón González Coro" Gynecologic and Obstetric Hospital
Havana, La Habana, Cuba, 10400